 | • レポートコード：B-GIR08C2071 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの世界市場について調べ、まとめました。種類別セグメントは、自己制作API、APIアウトソーシング等、用途別セグメントは、医療産業、IT産業、サービス産業等に区分しました。エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの世界市場概観、企業動向、企業別エムトリシタビン/リルピビリン/テノホビルアラフェンアミドシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの市場概観 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの企業別販売動向、市場シェア、市場集中度、競争動向 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの世界市場規模 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの北米市場分析（アメリカ、カナダ、メキシコ等） ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドのアメリカ市場規模推移 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドのカナダ市場規模推移 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドのメキシコ市場規模推移 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドのドイツ市場規模推移 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドのイギリス市場規模推移 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドのロシア市場規模推移 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの日本市場規模推移 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの中国市場規模推移 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの韓国市場規模推移 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドのインド市場規模推移 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの東南アジア市場規模推移 ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの南米市場分析（ブラジル、アルゼンチン等） ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの種類別分析/販売量、売上、市場シェア（自己制作API、APIアウトソーシング） ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの用途別分析/市場規模（医療産業、IT産業、サービス産業） ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Emtricitabine/Rilpivirine/Tenofovir Alafenamide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Emtricitabine/Rilpivirine/Tenofovir Alafenamide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Gilead Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Self-production API
Outsourcing of API
Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Emtricitabine/Rilpivirine/Tenofovir Alafenamide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Emtricitabine/Rilpivirine/Tenofovir Alafenamide, with price, sales, revenue and global market share of Emtricitabine/Rilpivirine/Tenofovir Alafenamide in 2017 and 2018.
Chapter 3, the Emtricitabine/Rilpivirine/Tenofovir Alafenamide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Emtricitabine/Rilpivirine/Tenofovir Alafenamide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Emtricitabine/Rilpivirine/Tenofovir Alafenamide market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Emtricitabine/Rilpivirine/Tenofovir Alafenamide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Introduction
1.2 Market Analysis by Type
1.2.1 Self-production API
1.2.2 Outsourcing of API
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drug Center
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Business Overview
2.1.2 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Gilead Sciences Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Manufacturer Market Share in 2018
3.3.2 Top 6 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Analysis by Regions
4.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Revenue and Market Share by Regions
4.1.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Market Share by Regions (2014-2019)
4.1.2 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Market Share by Regions (2014-2019)
4.2 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
4.3 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
4.5 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
5 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide by Country
5.1 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Revenue and Market Share by Country
5.1.1 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Market Share by Country (2014-2019)
5.1.2 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Market Share by Country (2014-2019)
5.2 United States Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
5.3 Canada Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
5.4 Mexico Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
6 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide by Country
6.1 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Revenue and Market Share by Country
6.1.1 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Market Share by Country (2014-2019)
6.1.2 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Market Share by Country (2014-2019)
6.2 Germany Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
6.3 UK Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
6.4 France Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
6.5 Russia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
6.6 Italy Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
7 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide by Country
7.1 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Market Share by Country (2014-2019)
7.2 China Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
7.3 Japan Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
7.4 Korea Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
7.5 India Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
8 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide by Country
8.1 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Revenue and Market Share by Country
8.1.1 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Market Share by Country (2014-2019)
8.1.2 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Market Share by Country (2014-2019)
8.2 Brazil Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
8.3 Argentina Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
8.4 Colombia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
9 Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide by Countries
9.1 Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
9.3 Turkey Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
9.4 Egypt Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
9.5 Nigeria Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
9.6 South Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
10 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Segment by Type
10.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Market Share by Type (2014-2019)
10.1.2 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Market Share by Type (2014-2019)
10.2 Self-production API Sales Growth and Price
10.2.1 Global Self-production API Sales Growth (2014-2019)
10.2.2 Global Self-production API Price (2014-2019)
10.3 Outsourcing of API Sales Growth and Price
10.3.1 Global Outsourcing of API Sales Growth (2014-2019)
10.3.2 Global Outsourcing of API Price (2014-2019)
11 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Segment by Application
11.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
11.4 Drug Center Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast (2019-2024)
12.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Revenue and Growth Rate (2019-2024)
12.2 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast by Regions (2019-2024)
12.2.1 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast (2019-2024)
12.2.2 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast (2019-2024)
12.2.3 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast (2019-2024)
12.2.4 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast (2019-2024)
12.2.5 Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast (2019-2024)
12.3 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast by Type (2019-2024)
12.3.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Forecast by Type (2019-2024)
12.3.2 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Share Forecast by Type (2019-2024)
12.4 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast by Application (2019-2024)
12.4.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Forecast by Application (2019-2024)
12.4.2 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Emtricitabine/Rilpivirine/Tenofovir Alafenamide Picture
Table Product Specifications of Emtricitabine/Rilpivirine/Tenofovir Alafenamide
Figure Global Sales Market Share of Emtricitabine/Rilpivirine/Tenofovir Alafenamide by Types in 2018
Table Emtricitabine/Rilpivirine/Tenofovir Alafenamide Types for Major Manufacturers
Figure Self-production API Picture
Figure Outsourcing of API Picture
Figure Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Figure United States Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure France Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure UK Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure China Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure India Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (Value) and Growth Rate (2014-2024)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Emtricitabine/Rilpivirine/Tenofovir Alafenamide Type and Applications
Table Gilead Sciences Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Manufacturer (2017-2018)
Figure Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Manufacturer in 2017
Figure Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Manufacturer in 2018
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Manufacturer (2017-2018)
Figure Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Manufacturer in 2017
Figure Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Manufacturer in 2018
Figure Top 3 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Manufacturer (Revenue) Market Share in 2018
Figure Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2014-2019)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Regions (2014-2019)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Regions (2014-2019)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Regions (2014-2019)
Figure Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Regions (2014-2019)
Figure Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Regions in 2018
Figure North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2014-2019)
Table North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Countries (2014-2019)
Table North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Countries (2014-2019)
Figure North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Countries (2014-2019)
Figure North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Countries in 2018
Table North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Countries (2014-2019)
Table North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Countries (2014-2019)
Figure North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Countries (2014-2019)
Figure North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Countries in 2018
Figure United States Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Canada Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Mexico Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2014-2019)
Table Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Countries (2014-2019)
Table Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Countries (2014-2019)
Table Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Countries (2014-2019)
Figure Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Countries (2014-2019)
Figure Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Countries in 2018
Figure Germany Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure UK Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure France Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Russia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Italy Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Countries (2014-2019)
Table Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Countries 2018
Table Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Countries (2014-2019)
Figure Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Countries 2018
Figure China Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Japan Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Korea Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure India Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Southeast Asia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2014-2019)
Table South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Countries (2014-2019)
Table South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Countries (2014-2019)
Figure South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Countries in 2018
Table South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Countries (2014-2019)
Table South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Countries (2014-2019)
Figure South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Countries in 2018
Figure Brazil Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Argentina Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Colombia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Countries (2014-2019)
Table Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Countries in 2018
Table Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Countries (2014-2019)
Table Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Countries in 2018
Figure Saudi Arabia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure UAE Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Egypt Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure Nigeria Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Figure South Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales and Growth Rate (2014-2019)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2014-2019)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Share by Type (2014-2019)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Type (2014-2019)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Share by Type (2014-2019)
Figure Global Self-production API Sales Growth (2014-2019)
Figure Global Self-production API Price (2014-2019)
Figure Global Outsourcing of API Sales Growth (2014-2019)
Figure Global Outsourcing of API Price (2014-2019)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2014-2019)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Share by Application (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Drug Center Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Revenue and Growth Rate (2019-2024)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Forecast by Regions (2019-2024)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Share Forecast by Regions (2019-2024)
Figure North America Sales Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast (2019-2024)
Figure Europe Sales Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast (2019-2024)
Figure Asia-Pacific Sales Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast (2019-2024)
Figure South America Sales Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast (2019-2024)
Figure Middle East and Africa Sales Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Forecast (2019-2024)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Forecast by Type (2019-2024)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Share Forecast by Type (2019-2024)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Forecast by Application (2019-2024)
Table Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Resear…- テノホビルアラフェンアミド及び併用薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Tenofovir Alafenamide and Its Combination Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years…
- ドルテグラビル/リルピビリン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Dolutegravir/Rilpivirine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on t…
- リルピビリンの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Rilpivirine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Rilpivirine in global marke…
- ドルテグラビル及び併用薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Dolutegravir and Its Combination Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…